Kenichi Ogiwara

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 13

Top Topics

Venous Thromboembolism

Direct Oral Anticoagulants

Protein Protein

Immune Response

Top Venues

International journal of hematology

Haemophilia : the official journal of the World Federation of Hemophilia

European journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Takashi Nakagawa, Kenichi Ogiwara, Hitoshi Tonegawa, Yukihiro Takahashi, Toshiya Nishikubo, Keiji Nogami
Anticoagulant effects of protein C, protein S, and antithrombin levels on the protein C pathway in young children. International journal of hematology 119 (2) (2024)
Takashi Nakagawa, Kenichi Ogiwara, Hitoshi Tonegawa, Yukihiro Takahashi, Toshiya Nishikubo, Keiji Nogami
Anticoagulant effects of protein C, protein S, and antithrombin levels on the protein C pathway in young children. International journal of hematology 119 (2) (2024)
Takashi Nakagawa, Kenichi Ogiwara, Hitoshi Tonegawa, Yukihiro Takahashi, Toshiya Nishikubo, Keiji Nogami
Anticoagulant effects of protein C, protein S, and antithrombin levels on the protein C pathway in young children. International journal of hematology 119 (2) (2024)
Takashi Nakagawa, Kenichi Ogiwara, Hitoshi Tonegawa, Yukihiro Takahashi, Toshiya Nishikubo, Keiji Nogami
Anticoagulant effects of protein C, protein S, and antithrombin levels on the protein C pathway in young children. International journal of hematology (2024)
Masahiro Takeyama, Naoki Matsumoto, Hiroto Abe, Suguru Harada, Kenichi Ogiwara, Shoko Furukawa, Naruto Shimonishi, Yuto Nakajima, Koji Yada, Tetsuhiro Soeda, Keiji Nogami
Coagulant potentials of emicizumab in the plasmas from infant and toddler patients with hemophilia A. Pediatric blood & cancer (2023)
Yuto Nakajima, Kenichi Ogiwara, Naruto Shimonishi, Shoko Furukawa, Masahiro Takeyama, Keiji Nogami
Intra-articular haemorrhage caused by reduced recovery of PEGylated recombinant factor VIII due to an anti-PEG antibody developed after mRNA-1273 SARS-CoV-2 vaccination in haemophilia A. Haemophilia : the official journal of the World Federation of Hemophilia (2023)
Naruto Shimonishi, Kenichi Ogiwara, Junko Yoshida, Kyoji Horie, Yuto Nakajima, Shoko Furukawa, Masahiro Takeyama, Keiji Nogami
Impaired factor V-related anticoagulant mechanisms and deep vein thrombosis associated with A2086D and W1920R mutations. Blood advances (2023)
Atsuko Nishiyama, Kenichi Ogiwara, Kuniyoshi Mizumachi, Naoki Hashimoto, Masahiro Takeyama, Keiji Nogami
Activated partial thromboplastin time-based clot waveform analysis enables measurement of very low levels of factor IX activity in patients with severe hemophilia B. International journal of hematology 116 (5) (2022)
Hiroaki Yaoi, Yasuaki Shida, Kenichi Ogiwara, Takehisa Kitazawa, Midori Shima, Keiji Nogami
Emicizumab enhances thrombus formation in vitro under high shear flow conditions in whole blood from patients with type 1 and type 3 von Willebrand disease. Haemophilia : the official journal of the World Federation of Hemophilia 28 (5) (2022)
Atsuko Nishiyama, Kenichi Ogiwara, Yuto Nakajima, Shoko Furukawa, Tomoko Matsumoto, Hiroki Takeda, Keiji Nogami
A case of a young boy with hyper-fibrinolysis associated with natural fibrin precipitates suspected to have occurred through a novel coagulation and fibrinolysis mechanism. International journal of hematology 116 (2) (2022)
Naoki Hashimoto, Kenichi Ogiwara, Naruto Shimonishi, Takashi Nakagawa, Yuto Nakajima, Shoko Furukawa, Masahiro Takeyama, Keiji Nogami
Screening of the protein C pathway abnormality-related thrombophilia by using thrombomodulin-mediated tissue factor-triggered clot waveform analysis. European journal of haematology 109 (1) (2022)
Kenichi Ogiwara, Masashi Taki, Takashi Suzuki, Hideyuki Takedani, Tadashi Matsushita, Kagehiro Amano, Masanori Matsumoto, Kenji Nishio, Midori Shima, Masato Kasahara, Keiji Nogami
Assessment of global coagulation function under treatment with emicizumab concomitantly with bypassing agents in haemophilia A with inhibitor (UNEBI Study): multicentre open-label non-randomised clinical trial. BMJ open 12 (2) (2022)
Mai Watakabe, Yasuaki Shida, Kenichi Ogiwara, Yusuke Inagaki, Keiji Nogami
A mild hemophilia B case with postoperative bleeds following thromboprophylaxis. Pediatrics international : official journal of the Japan Pediatric Society 64 (1) (2022)